Wegovy Heartburn: How Common, How Long It Lasts, What Helps
Yes. In the Wegovy trials, 9% of people on 2.4 mg had heartburn and indigestion, against 3% on placebo: about 3 times the placebo rate. It is the seventh most common side effect in that table. Smaller, slower meals help most.
- In the Wegovy label
- Yes, with a rate
- On Wegovy 2.4 mg
- 9%
- On placebo
- 3%
- Rank in the label table
- 7 of 19
Wegovy overview
The half-life is about 1 week. After 7 d, half is gone. About 3% remains after five half-lives (35 d).
In STEP 1, the change in body weight at 68 weeks was 14.9%, against 2.4% on placebo.
Monthly prices are listed in US dollars. They include the list price and self-pay offers, with each one taken from the maker's price page.
Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.
How common it is on Wegovy and with placebo
The label trials report Wegovy heartburn by dose The comparison group from that same trial is the placebo group. A placebo is the comparison group in the same trial.
| Medicine and dose | Heartburn and indigestion | Placebo | More than placebo | People in the trials |
|---|---|---|---|---|
| Wegovy 2.4 mg | 9% | 3% | +6 points | For weight management: adults living with obesity or overweight (label term: dyspepsia) |
| Wegovy 2.4 mg | 5% | 3% | +2 points | Used for weight management in adults with obesity, or adults who are overweight (label term: gastroesophageal reflux disease) |
| Wegovy 2.4 mg | 4% | 2% | +2 points | Children aged 12 and older with obesity (label term: gastroesophageal reflux disease) |
Taken from the Wegovy label (DailyMed).
Heartburn: Wegovy compared with the other GLP-1s
Each label covers its own trials, which included different groups of people. Consider it a rough guide.
The table also lists the pill forms: Foundayo.
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
 Foundayo | 16% | 9 mg | 4% | Adults with obesity or overweight (weight management) |
 Zepbound | 10% | 15 mg | 4% | Adults with obesity or overweight (weight management) |
 Saxenda | 9.6% | all doses | 2.7% | Adults with obesity or overweight (weight management) |
| Wegovy | 9% | 2.4 mg | 3% | Adults with obesity or overweight (weight management) |
 Mounjaro | 8% | 5 mg | 3% | Adults with type 2 diabetes |
 Victoza | 7% | 1.8 mg | 1% | Adults with type 2 diabetes |
| Byetta | 6% | all doses | 3% | Adults with type 2 diabetes |
 Trulicity | 5.8% | 1.5 mg | 2.3% | Adults with type 2 diabetes |
 Ozempic | Listed, no rate given | – | – | – |
 Rybelsus | Listed, no rate given | – | – | – |
Sources: Wegovy label (DailyMed), Mounjaro label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed), Trulicity label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), Byetta label (DailyMed).
Source: FDA label (DailyMed).
Why it happens on Wegovy
These medicines slow how quickly the stomach empties. Because food sits longer, heartburn and indigestion can follow. That happens most of all after meals that are big or fatty.
Source: health.clevelandclinic.org.
What Wegovy’s label says
Here the label names heartburn and indigestion word for word:
“that occurred at a higher incidence among WEGOVY injection-treated adult patients included dyspepsia, abdominal pain, abdominal distension, eructation, flatulence, gastroesophageal reflux disease, gastritis, hemorrhoids, and”
Source: FDA label (DailyMed).
What helps, step by step
- For now, avoid spicy and fatty foods.
- Stay upright after meals instead of lying down.
- Select smaller meals, and stop eating when you feel full. These medicines make the stomach empty more slowly.
- Eat slowly. It takes time for your brain to notice that you are full.
- Reduce fatty, greasy and sugary foods because they often cause symptoms.
- Tell your prescriber if it does not ease. Your prescriber may increase the dose more slowly or recommend another GLP-1.
Before taking any drugstore product, check it with the GLP-1 interactions checker.
Source: health.clevelandclinic.org.